Entegris
ENTG
166.32
-0.57
-0.34%
Entegris
US · ENTG
#831 by market cap
Listed 1970
166.32
-0.57
-0.34%
Live - 5344 symbols - heartbeat 77s ago
· 2026-10-08 08:33
Pre-market
162.08
-2.55%
After-hours
167.05
+0.44%
Overnight
164.75
-0.94%
- Market cap
- 25.41B
- P/E (TTM)i
- 83.16
- P/Bi
- 6.11
- EPSi
- 1.55
- Div yieldi
- 0.24%
- 52W posi
- 83%
Reader sentiment
Are you bullish or bearish on ENTG?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.64, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -1.38% YoY
Margins
- Gross margin
- 44.42%
- Operating margin
- 28.89%
- Net margin
- 7.37%
Key ratios & quality
- PEG ratioi
- 20.34
- Altman Z-Scorei
- 4.64
PEG uses trailing P/E against the 3-year net income growth rate (4.09%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.55B | 1.59B | 1.86B | 2.30B | 3.28B | 3.52B | 3.24B | 3.20B |
| Gross profit | 719.83M | 711.65M | 849.72M | 1.06B | 1.40B | 1.50B | 1.49B | 1.42B |
| Selling & admin expenses | 246.53M | 284.81M | 265.13M | 292.41M | 543.49M | 576.20M | 446.60M | -17.00M |
| Research & development | 118.46M | 121.14M | 136.06M | 167.63M | 228.99M | 277.30M | 316.10M | 329.00M |
| Operating profit | 292.69M | 239.28M | 395.45M | 551.77M | 479.98M | 429.60M | 533.90M | 923.50M |
| Pretax profit | 254.43M | 318.05M | 354.29M | 479.08M | 247.08M | 172.70M | 322.00M | 254.60M |
| Tax | 13.68M | 63.19M | 59.32M | 69.95M | 38.16M | -8.40M | 28.30M | 18.00M |
| Net profit | 240.76M | 254.86M | 294.97M | 409.13M | 208.92M | 180.70M | 292.80M | 235.60M |
| Basic EPS | 2 | 2 | 2 | 3 | 1 | 1 | 2 | 2 |
| Diluted EPS | 1.69 | 1.87 | 2.16 | 3.00 | 1.46 | 1.20 | 1.93 | 1.55 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 773.20M | 792.40M | 807.10M | 823.90M | 811.90M | 883.20M |
| Gross profit | 356.50M | 351.50M | 351.30M | 360.60M | 380.80M | 420.00M |
| Selling & admin expenses | 103.30M | 115.10M | 101.40M | -334.20M | 117.60M | 131.30M |
| Research & development | 84.80M | 84.30M | 80.90M | 79.00M | 75.30M | 82.80M |
| Operating profit | 122.30M | 106.10M | 123.00M | 569.50M | 141.60M | 159.80M |
| Pretax profit | 71.40M | 55.80M | 72.30M | 55.10M | 93.20M | 110.10M |
| Tax | 8.20M | 2.80M | 1.50M | 5.50M | 1.00M | 16.50M |
| Net profit | 62.90M | 52.80M | 70.50M | 49.40M | 92.00M | 93.60M |
| Basic EPS | 0 | 0 | 0 | 0 | 1 | 1 |
| Diluted EPS | 0.41 | 0.35 | 0.46 | 0.32 | 0.60 | 0.61 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.03B | 932.40M | 1.23B | 1.31B | 2.34B | 1.98B | 1.62B | 1.64B |
| Cash & ST investments | 482.06M | 351.91M | 580.89M | 402.57M | 561.56M | 456.93M | 329.20M | 360.40M |
| Inventory | 268.14M | 287.10M | 323.94M | 475.21M | 812.82M | 607.05M | 638.10M | 643.20M |
| Total assets | 2.32B | 2.52B | 2.92B | 3.19B | 10.14B | 8.81B | 8.39B | 8.35B |
| Total current liabilities | 269.67M | 264.43M | 302.63M | 379.00M | 761.93M | 514.00M | 525.20M | 488.60M |
| Short-term debt | 4.00M | 4.00M | -- | -- | 151.97M | -- | -- | -- |
| Long-term debt | 934.86M | 932.48M | 1.09B | 937.03M | 5.63B | 4.58B | 3.98B | 3.70B |
| Total liabilities | 1,305,616,000.00 | 1,350,197,000.00 | 1,538,202,000.00 | 1,478,115,000.00 | 6,920,857,000.00 | 5,403,997,000.00 | 4,703,100,000.00 | 4,397,100,000.00 |
| Total equity | 1.01B | 1.17B | 1.38B | 1.71B | 3.22B | 3.41B | 3.69B | 3.95B |
| Retained earnings | 213.75M | 366.13M | 577.83M | 879.78M | 1.03B | 1.15B | 1.38B | 1.56B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.67B | 1.71B | 1.70B | 1.64B | 1.79B | 1.78B |
| Cash & ST investments | 340.90M | 376.80M | 399.80M | 360.40M | 442.70M | 353.60M |
| Inventory | 671.50M | 694.60M | 646.80M | 643.20M | 644.40M | 703.90M |
| Total assets | 8.43B | 8.45B | 8.40B | 8.35B | 8.48B | 8.42B |
| Total current liabilities | 512.60M | 517.20M | 492.70M | 488.60M | 555.60M | 585.40M |
| Short-term debt | -- | 50.00M | -- | -- | -- | -- |
| Long-term debt | 3.98B | 3.94B | 3.84B | 3.70B | 3.65B | 3.46B |
| Total liabilities | 4,682,000,000.00 | 4,640,400,000.00 | 4,511,000,000.00 | 4,397,100,000.00 | 4,425,900,000.00 | 4,262,300,000.00 |
| Total equity | 3.75B | 3.81B | 3.89B | 3.95B | 4.05B | 4.16B |
| Retained earnings | 1.43B | 1.47B | 1.52B | 1.56B | 1.64B | 1.71B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 312.58M | 382.30M | 446.67M | 400.45M | 363.13M | 644.50M | 631.70M | 695.40M |
| Depreciation & amortization | 127.27M | 141.40M | 136.52M | 138.17M | 279.32M | 387.20M | 378.20M | 389.70M |
| Free cash flow | 202.42M | 269.94M | 314.92M | 189.83M | -103.06M | 187.70M | 316.10M | 396.20M |
| Dividends paid | -39.59M | -40.57M | -43.25M | -43.55M | -57.31M | -60.20M | -60.60M | -60.80M |
| Stock buybacks / issuance | -173.78M | -80.32M | -44.56M | -67.11M | -- | -- | -- | -- |
| Ending cash balance | 482.06M | 351.91M | 580.89M | 402.57M | 563.44M | 456.90M | 329.20M | 360.40M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 140.40M | 113.50M | 249.50M | 192.00M | 183.00M | 156.20M |
| Depreciation & amortization | 96.00M | 97.30M | 96.40M | 100.00M | 80.40M | 80.50M |
| Free cash flow | 32.40M | 47.00M | 182.80M | 134.00M | 141.50M | 116.90M |
| Dividends paid | -15.40M | -15.20M | -15.10M | -15.10M | -15.40M | -15.40M |
| Stock buybacks / issuance | 1.40M | 100.00K | 2.10M | -- | 14.30M | 18.20M |
| Ending cash balance | 340.90M | 376.80M | 399.80M | 360.40M | 442.70M | 353.60M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 24.01 | 23.40 | 23.18 | 26.45 | 8.47 | 5.45 | 8.25 | 6.16 |
| ROA %i | 11.21 | 10.55 | 10.86 | 13.39 | 3.13 | 1.91 | 3.40 | 2.81 |
| ROIC %i | 14.89 | 14.10 | 14.41 | 17.03 | 6.46 | 4.93 | 6.11 | 5.34 |
| 5-year avg ROE %i | 11.16 | 15.64 | 18.20 | 21.21 | 21.10 | 17.39 | 14.36 | 10.96 |
| EBIT margin %i | 18.61 | 22.94 | 21.67 | 22.63 | 14.01 | 13.76 | 16.58 | 14.22 |
| FCF / sales %i | 13.06 | 16.97 | 16.94 | 8.26 | -- | 4.90 | 9.75 | 12.39 |
| Current ratioi | 3.82 | 3.53 | 4.08 | 3.47 | 3.06 | 3.85 | 3.08 | 3.35 |
| Quick ratioi | 2.68 | 2.31 | 2.86 | 2.07 | 1.50 | 1.90 | 1.65 | 1.75 |
| Debt / assetsi | 40.51 | 38.96 | 38.58 | 31.24 | 57.85 | 52.72 | 48.28 | 45.46 |
| LT debt / equityi | 92.38 | 83.74 | 81.59 | 58.18 | 177.55 | 136.31 | 109.80 | 96.02 |
| Interest coveragei | 8.46 | 7.77 | 8.29 | 12.62 | 2.16 | 1.55 | 2.50 | 2.27 |
| Revenue CAGR (3Y) %i | 12.77 | 10.62 | 11.47 | 14.03 | 27.30 | 23.75 | 12.13 | -0.88 |
| Net income CAGR (3Y) %i | 44.20 | 37.92 | 51.36 | 19.33 | -6.41 | -15.07 | -10.55 | 4.09 |
| FCF CAGR (3Y) %i | 60.52 | 23.79 | 16.38 | -2.12 | -- | -15.84 | 18.53 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 8.65 | 8.08 | 7.71 | 6.16 | 6.79 | 7.67 |
| ROA %i | 3.70 | 3.52 | 3.42 | 2.81 | 3.13 | 3.62 |
| ROIC %i | 6.38 | 6.13 | 6.07 | 5.34 | 5.72 | 6.15 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 17.06 | 16.55 | 16.01 | 14.22 | 14.65 | 15.77 |
| FCF / sales %i | 8.26 | 8.16 | 10.27 | 12.39 | 15.62 | 17.29 |
| Current ratioi | 3.26 | 3.30 | 3.44 | 3.35 | 3.21 | 3.05 |
| Quick ratioi | 1.72 | 1.77 | 1.91 | 1.75 | 1.80 | 1.61 |
| Debt / assetsi | 48.10 | 48.01 | 46.52 | 45.46 | 44.34 | 42.29 |
| LT debt / equityi | 108.16 | 105.17 | 100.44 | 96.02 | 92.80 | 85.66 |
| Interest coveragei | 2.65 | 2.57 | 2.53 | 2.27 | 2.40 | 2.71 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Advanced Purity Solutions (APS) is the largest reported line at 58.27% of revenue, across 3 reported segments.
- Materials Solutions (MS) follows at 42.04%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Advanced Purity Solutions (APS)58.27%
Materials Solutions (MS)42.04%
Quote time 2026-10-08 08:33:41 · For reference only, not investment advice and not tailored to your situation.